ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

ClinicalTrials.gov ID: NCT05774184

Public ClinicalTrials.gov record NCT05774184. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults With Active Eosinophilic Esophagitis (The "EvolvE" Study)

Study identification

NCT ID
NCT05774184
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celldex Therapeutics
Industry
Enrollment
86 participants

Conditions and interventions

Interventions

  • Matching Placebo Drug
  • barzolvolimab Biological

Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2023
Primary completion
Jun 3, 2025
Completion
Jan 22, 2026
Last update posted
Apr 30, 2026

2023 – 2026

United States locations

U.S. sites
24
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
AllerVie Clinical Research Birmingham Alabama 35209
One of a Kind Clinical Research Center Scottsdale Arizona 85258
GI Alliance- Arizona Digestive Health- Sun City Sun City Arizona 85351
Del Sol Research Management, LLC Tucson Arizona 85715
GW Research Inc. Chula Vista California 91910
Connecticut Clinical Research Institute, LLC Bristol Connecticut 06416
ENCORE Borland Groover Clinical Research Jacksonville Florida 32256
Gastroenterology of Greater Orlando Orange City Florida 32763
Treasure Valley Medical Research Boise Idaho 83706
Northwestern University Chicago Illinois 60208
University of Iowa Iowa City Iowa 52242
University of Kansas Medical Center (KUMC) Kansas City Kansas 66160
Tandem Clinical Research Marrero Louisiana 70072
Boston Specialists - Boston Food Allergy Center Boston Massachusetts 02111
NYU Langone Health New York New York 10016
University of North Carolina (UNC) Hospitals Chapel Hill North Carolina 27514
Duke University Medical Center Durham North Carolina 27710
The Clinical Trials Network, LLC Willoughby Ohio 44096
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center Hershey Pennsylvania 17033
University of Pennsylvania Philadelphia Pennsylvania 19104
Vanderbilt University Medical Center-GI Clinical Research Program Nashville Tennessee 37232
Advanced Research Institute - Ogden Ogden Utah 84405
Care Access Research Salt Lake City Utah 84124
University of Utah Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05774184, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05774184 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →